STN— AI Stock Forecast & Price Targets
Published 6/14/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live STN price forecast →
Stantec has sold off ~33% over the past year to C$72.26 despite double-digit revenue growth, strong backlog momentum from multi-year water infrastructure wins (Brandon Road, Greater Western Water), and a forward P/E of ~14.5x — well below historical levels for a defensive E&C compounder. Near-term technicals remain bearish (price -24.6% vs SMA200, RSI 34) but the stock is testing the 52-week low at C$70.84, offering an attractive risk/reward against analyst target of C$107.79 and Kronos 1d/4h forecasts pointing to mean reversion toward C$83-100.
Initiate a starter long position (1/3 size) at current C$72.26, with hard stop on weekly close below C$68 (below 52w low of C$70.84). RSI 34 + Kronos near-term bullish probability of 1.0 + proximity to 52w support justify a tactical entry. First target C$78-80 (gap fill / SMA20 reclaim) for +8-10% trade. Invalidation: break of C$70 on volume, or any management commentary suggesting backlog softness at Q2 earnings.
Over 1-6 months the thesis is mean reversion as the market repents the dislocation between fundamentals (15.8% EPS Q/Q, FCF yield ~9%, recent water mega-contracts) and a forward P/E of 14.5x for a 14.7% EPS-5Y grower (PEG 0.98). Expected return range +15% to +35% to C$83-95, anchored by Kronos 4h forecast (C$100.94) and consensus target (C$107.79). Catalysts: Q2 2026 earnings, additional Army Corps / water utility contract announcements, BoC/Fed rate cuts supporting cyclical re-rating. Mind-changer: margin compression continuing in Q2 (operating margin <8%), or organic growth deceleration below 5%.
Over 1-3 years Stantec remains a high-quality secular winner in climate adaptation, water infrastructure, and ecosystem engineering — end-markets backed by US IIJA, EPA mandates, and global water scarcity. With 10%+ revenue CAGR, 15%+ ROE, and disciplined M&A (recent balance sheet expansion suggests another sizeable acquisition is being digested), EPS of ~C$7-8 by 2028 at a 20x multiple supports C$140-160. Biggest structural risks: (1) federal/state infrastructure budget cuts under fiscal tightening, (2) inability to organically grow as bolt-on M&A matures, (3) integration risk from the recent asset increase (~C$1.1B in new assets Q3'25 to Q1'26).
Revenue growth remains healthy: TTM sales of C$6.64B with Sales Y/Y TTM +8.3% and 3/5Y CAGRs of 10.2%/10.6%. Quarterly revenue trajectory shows resilience (Q1'26 C$2.07B vs Q2'25 C$1.96B), though Q1 operating margin (8.3%) compressed vs Q3'25 (10.4%), suggesting some project mix or integration drag. Profitability metrics are solid: ROE 15.3-15.7%, ROIC 8.88%, gross margin 54.2% (Yahoo) / 39% (Finviz, likely different definition), and EBITDA of ~C$980M. Balance sheet shows elevated but manageable leverage: total debt C$2.59B vs equity C$3.38B (D/E 0.77), current ratio 1.35 — note total assets jumped from C$6.97B (Q2'25) to C$8.04B (Q1'26), implying a sizeable acquisition was funded with debt. Free cash flow is the standout: TTM FCF C$739M against C$8.24B market cap = ~9% FCF yield, with P/FCF of 16.8x. The one blemish is Q1'26 operating cash flow of -C$2.3M, which is likely working-capital seasonality but warrants monitoring. Capital allocation is balanced: 21.4% payout, 5-yr dividend growth 6.8%, while reinvesting in tuck-in M&A.
Across all timeframes the stock is in a clear downtrend: weekly chart shows a peak near C$112 in mid-2025 collapsing to C$72.26 (-35%), with the 1d chart confirming a sharp May 2026 breakdown from ~C$92 to current levels. Price sits -3.6% below SMA20, -12.9% below SMA50 and -24.6% below SMA200 — a classic capitulation pattern. RSI(14) at 34.1 is oversold but not extreme. The 52-week low at C$70.84 is critical near-term support; loss of it opens C$65. Kronos forecasts are constructive: the 1h forecast (C$83.72) and 4h forecast (C$100.94) both project meaningful mean reversion, and the 1wk forecast band straddles C$72-88, suggesting basing rather than continued decline. However, the accuracy table is a major caveat — directional accuracy at horizons 3+ is essentially 0% with MAPE rising to 27%, so the magnitude of the bullish forecast should be discounted heavily; only the 1-2 day signal (~55-58% accuracy) carries weight. The 1h chart's tight tracking of forecast vs actual is the most credible bullish technical signal.
Signal: Stantec is racking up large, multi-year water infrastructure wins — the US$85M Brandon Road Interbasin contract with Black & Veatch (8-year duration) and the Jacobs-Stantec JV for Greater Western Water's 5-year Melbourne program. Both reinforce Stantec's positioning in scarcity-driven water/climate-resilience spending, a secular tailwind. Simply Wall St. and Seeking Alpha both flag the valuation gap created by the recent ~28% drawdown, and Insider Monkey lists STN among best water infrastructure scarcity-trend names. Noise: The crypto/Trump-related items in the broader market block are irrelevant to STN. The DuPont MemCor Sydney story is tangential — it's a competitor product in the same end-market but doesn't directly impact Stantec's backlog. Net read: news flow is unambiguously positive on backlog and analyst sentiment (Recom 1.25 = strong buy, target C$107.79 = +49% upside), creating dissonance with the price action which appears driven by macro/sector de-rating rather than company-specific deterioration.
- US$85M, 8-year Brandon Road Interbasin Project with Black & Veatch JV (US Army Corps) — locks in multi-year revenue and reinforces aquatic ecosystem credentials
- 5-year Greater Western Water infrastructure planning & delivery program (Melbourne) with Jacobs JV — expands ANZ water platform and recurring revenue base
- Water scarcity / climate-resilience secular thesis: Stantec named among top water infrastructure plays by analysts (Insider Monkey Jun 2026)
- Balance sheet growth (assets +C$1.1B Q3'25-Q1'26) implies recent acquisition that should layer onto FY26-27 revenue once fully consolidated
- Forward EPS growth 14.7% / 5Y consensus with EPS Q/Q already at +15.8% — operating leverage as larger contracts ramp
- Technical downtrend remains intact: -24.6% vs SMA200, -33% YoY, -23.4% YTD — knife-catching risk if 52w low C$70.84 breaks
- Q1'26 operating cash flow turned negative (-C$2.3M) vs C$312M in Q4'25 — working capital or contract billing issue worth monitoring
- Debt/Equity at 0.77 and rising (total debt grew C$447M YoY) raises leverage just as rate environment remains restrictive
- Kronos forecast accuracy is essentially zero beyond 3-day horizon (directional accuracy 0% at H6-12, MAPE 19-27%) — do not over-rely on multi-week forecast magnitude
- Cyclical exposure: E&C names de-rate sharply on infrastructure budget cuts; US fiscal trajectory and election cycle are wild cards
- Operating margin compressed to 8.3% in Q1'26 from 10.4% in Q3'25 — could signal project mix or integration friction
- Beta 0.72-1.00 understates drawdown risk — actual 1Y performance -33% shows when sentiment turns, the multiple compression is severe
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord